FOUND: Isabelle kenyon - You Need To See This

CEO of Ozempic prescription startup Calibrate steps down as investors eye ‘rapid downsizing’ of consumer business

Calibrate CEO Isabelle Kenyon is stepping down as chief executive and will no longer oversee day-to-day operations.

Fortune · Oct 30, 2023

Hyped weight loss drugs raise supply, equity concerns

Sales of the buzzy new class of diabetes drugs have skyrocketed more than 2,000% in 4 years, data from Komodo Health shows.

Axios · Feb 13, 2023

‘I miss eating’: the truth behind the weight loss drug that makes food repulsive

In Beverly Hills’ doctors offices, celebrities are clamoring for Ozempic prescriptions – but what are the costs of the supposed wonder drug?

The Guardian - US · Nov 9, 2022